HIV molecular immunology database


Search Antibody Database

Found 1 matching record:

Displaying record number 1829

Download this epitope record as JSON.

HXB2 Location gp160(146-151)
gp160 Epitope Map
Author Location gp120
Research Contact Nina Derby or Leo Stamatatos, Seattle Biomedical Research Institute, Seattle, WA, USA,
Epitope WKEM(D/N)R Epitope Alignment
WKEM(D/N)R epitope logo
Subtype B
Ab Type gp120 V1
Neutralizing L
Species (Isotype) mouse(IgG1κ)
Immunogen vaccine
Country United States
Keywords antibody binding site, neutralization

Vaccine Details

Vaccine type protein
Vaccine strain B clade SF162
Vaccine component gp140ΔV2


Showing 2 of 2 notes.


Showing 2 of 2 references.

Isolation Paper
Derby2007 Nina R. Derby, Sean Gray, Elizabeth Wayner, Dwayne Campogan, Giorgos Vlahogiannis, Zane Kraft, Susan W. Barnett, Indresh K. Srivastava, and Leonidas Stamatatos. Isolation and Characterization of Monoclonal Antibodies Elicited by Trimeric HIV-1 Env gp140 Protein Immunogens. Virology, 366(2):433-445, 30 Sep 2007. PubMed ID: 17560621. Show all entries for this paper.

Ching2008 Lance K. Ching, Giorgos Vlachogiannis, Katherine A. Bosch, and Leonidas Stamatatos. The First Hypervariable Region of the gp120 Env Glycoprotein Defines the Neutralizing Susceptibility of Heterologous Human Immunodeficiency Virus Type 1 Isolates to Neutralizing Antibodies Elicited by the SF162gp140 Immunogen. J. Virol., 82(2):949-956, Jan 2008. PubMed ID: 18003732. Show all entries for this paper.

Questions or comments? Contact us at
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health